Logo image of HR

HEALTHCARE REALTY TRUST INC (HR) Stock Fundamental Analysis

NYSE:HR - New York Stock Exchange, Inc. - US42226K1051 - REIT - Currency: USD

15.32  +0.11 (+0.72%)

After market: 15.5 +0.18 (+1.17%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to HR. HR was compared to 129 industry peers in the Diversified REITs industry. Both the profitability and financial health of HR have multiple concerns. HR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year HR has reported negative net income.
HR had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: HR reported negative net income in multiple years.
Each year in the past 5 years HR had a positive operating cash flow.
HR Yearly Net Income VS EBIT VS OCF VS FCFHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B -1.5B -2B

1.2 Ratios

HR has a Return On Assets of -6.73%. This is amonst the worse of the industry: HR underperforms 86.82% of its industry peers.
HR has a worse Return On Equity (-13.90%) than 78.29% of its industry peers.
HR has a Return On Invested Capital of 0.44%. This is amonst the worse of the industry: HR underperforms 86.82% of its industry peers.
The Average Return On Invested Capital over the past 3 years for HR is below the industry average of 3.17%.
The 3 year average ROIC (0.38%) for HR is below the current ROIC(0.44%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -6.73%
ROE -13.9%
ROIC 0.44%
ROA(3y)-2.72%
ROA(5y)-1.19%
ROE(3y)-5.41%
ROE(5y)-2.31%
ROIC(3y)0.38%
ROIC(5y)1.07%
HR Yearly ROA, ROE, ROICHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10

1.3 Margins

With a Operating Margin value of 3.58%, HR is not doing good in the industry: 86.82% of the companies in the same industry are doing better.
HR's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 62.46%, HR is not doing good in the industry: 65.89% of the companies in the same industry are doing better.
HR's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.58%
PM (TTM) N/A
GM 62.46%
OM growth 3Y-49.95%
OM growth 5Y-33.08%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.21%
GM growth 5Y-2.03%
HR Yearly Profit, Operating, Gross MarginsHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

2

2. Health

2.1 Basic Checks

HR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, HR has less shares outstanding
The number of shares outstanding for HR has been increased compared to 5 years ago.
HR has a worse debt/assets ratio than last year.
HR Yearly Shares OutstandingHR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
HR Yearly Total Debt VS Total AssetsHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of 0.18, we must say that HR is in the distress zone and has some risk of bankruptcy.
HR has a Altman-Z score of 0.18. This is in the lower half of the industry: HR underperforms 66.67% of its industry peers.
HR has a debt to FCF ratio of 34.28. This is a negative value and a sign of low solvency as HR would need 34.28 years to pay back of all of its debts.
HR's Debt to FCF ratio of 34.28 is fine compared to the rest of the industry. HR outperforms 62.79% of its industry peers.
A Debt/Equity ratio of 0.95 indicates that HR is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.95, HR perfoms like the industry average, outperforming 59.69% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF 34.28
Altman-Z 0.18
ROIC/WACC0.07
WACC6.71%
HR Yearly LT Debt VS Equity VS FCFHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B

2.3 Liquidity

HR has a Current Ratio of 0.07. This is a bad value and indicates that HR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.07, HR is doing worse than 96.90% of the companies in the same industry.
HR has a Quick Ratio of 0.07. This is a bad value and indicates that HR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of HR (0.07) is worse than 96.90% of its industry peers.
Industry RankSector Rank
Current Ratio 0.07
Quick Ratio 0.07
HR Yearly Current Assets VS Current LiabilitesHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 14.93% over the past year.
Looking at the last year, HR shows a quite strong growth in Revenue. The Revenue has grown by 17.17% in the last year.
The Revenue has been growing by 12.88% on average over the past years. This is quite good.
EPS 1Y (TTM)14.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%343.75%
Revenue 1Y (TTM)17.17%
Revenue growth 3Y18.25%
Revenue growth 5Y12.88%
Sales Q2Q%-8.51%

3.2 Future

HR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.62% yearly.
HR is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.07% yearly.
EPS Next Y69.65%
EPS Next 2Y29.9%
EPS Next 3Y18.62%
EPS Next 5YN/A
Revenue Next Year-3.73%
Revenue Next 2Y-0.7%
Revenue Next 3Y-1.45%
Revenue Next 5Y-1.07%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HR Yearly Revenue VS EstimatesHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
HR Yearly EPS VS EstimatesHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 -1 -1.5

2

4. Valuation

4.1 Price/Earnings Ratio

HR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year HR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HR Price Earnings VS Forward Price EarningsHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as HR.
Based on the Price/Free Cash Flow ratio, HR is valued a bit cheaper than 63.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF 38.36
EV/EBITDA 14.37
HR Per share dataHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

HR's earnings are expected to grow with 18.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.9%
EPS Next 3Y18.62%

6

5. Dividend

5.1 Amount

HR has a Yearly Dividend Yield of 8.16%, which is a nice return.
Compared to an average industry Dividend Yield of 6.70, HR pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.44, HR pays a better dividend.
Industry RankSector Rank
Dividend Yield 8.16%

5.2 History

The dividend of HR has a limited annual growth rate of 0.57%.
HR has been paying a dividend for at least 10 years, so it has a reliable track record.
HR has decreased its dividend recently.
Dividend Growth(5Y)0.57%
Div Incr Years0
Div Non Decr Years1
HR Yearly Dividends per shareHR Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

The earnings of HR are negative and hence is the payout ratio. HR will probably not be able to sustain this dividend level.
HR's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-63.52%
EPS Next 2Y29.9%
EPS Next 3Y18.62%
HR Yearly Income VS Free CF VS DividendHR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B

HEALTHCARE REALTY TRUST INC

NYSE:HR (5/8/2025, 6:40:00 PM)

After market: 15.5 +0.18 (+1.17%)

15.32

+0.11 (+0.72%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)05-01 2025-05-01/amc
Earnings (Next)07-31 2025-07-31/bmo
Inst Owners107.75%
Inst Owner Change1.13%
Ins Owners0.39%
Ins Owner Change20.79%
Market Cap5.38B
Analysts51.58
Price Target17.79 (16.12%)
Short Float %3.62%
Short Ratio4.54
Dividend
Industry RankSector Rank
Dividend Yield 8.16%
Yearly Dividend1.25
Dividend Growth(5Y)0.57%
DP-63.52%
Div Incr Years0
Div Non Decr Years1
Ex-Date05-12 2025-05-12 (0.31)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)115.28%
Min EPS beat(2)-290.16%
Max EPS beat(2)520.71%
EPS beat(4)1
Avg EPS beat(4)-112.45%
Min EPS beat(4)-377.54%
Max EPS beat(4)520.71%
EPS beat(8)2
Avg EPS beat(8)-73.2%
EPS beat(12)3
Avg EPS beat(12)15.92%
EPS beat(16)6
Avg EPS beat(16)23.38%
Revenue beat(2)0
Avg Revenue beat(2)-1.72%
Min Revenue beat(2)-2.27%
Max Revenue beat(2)-1.18%
Revenue beat(4)0
Avg Revenue beat(4)-2.04%
Min Revenue beat(4)-4.19%
Max Revenue beat(4)-0.53%
Revenue beat(8)1
Avg Revenue beat(8)-1.36%
Revenue beat(12)2
Avg Revenue beat(12)6.44%
Revenue beat(16)2
Avg Revenue beat(16)2.39%
PT rev (1m)0.35%
PT rev (3m)-2.41%
EPS NQ rev (1m)-9.76%
EPS NQ rev (3m)2.7%
EPS NY rev (1m)0.86%
EPS NY rev (3m)14.76%
Revenue NQ rev (1m)0.19%
Revenue NQ rev (3m)-2.85%
Revenue NY rev (1m)-0.48%
Revenue NY rev (3m)-3.13%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.43
P/FCF 38.36
P/OCF 11.36
P/B 1.06
P/tB 1.06
EV/EBITDA 14.37
EPS(TTM)-0.57
EYN/A
EPS(NY)-0.35
Fwd EYN/A
FCF(TTM)0.4
FCFY2.61%
OCF(TTM)1.35
OCFY8.8%
SpS4.47
BVpS14.47
TBVpS14.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.73%
ROE -13.9%
ROCE 0.55%
ROIC 0.44%
ROICexc 0.44%
ROICexgc 0.46%
OM 3.58%
PM (TTM) N/A
GM 62.46%
FCFM 8.94%
ROA(3y)-2.72%
ROA(5y)-1.19%
ROE(3y)-5.41%
ROE(5y)-2.31%
ROIC(3y)0.38%
ROIC(5y)1.07%
ROICexc(3y)0.38%
ROICexc(5y)1.09%
ROICexgc(3y)0.39%
ROICexgc(5y)1.1%
ROCE(3y)0.48%
ROCE(5y)1.36%
ROICexcg growth 3Y-49.37%
ROICexcg growth 5Y-31.73%
ROICexc growth 3Y-49.34%
ROICexc growth 5Y-31.78%
OM growth 3Y-49.95%
OM growth 5Y-33.08%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.21%
GM growth 5Y-2.03%
F-Score5
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF 34.28
Debt/EBITDA 6.82
Cap/Depr 51.4%
Cap/Sales 21.25%
Interest Coverage 0.29
Cash Conversion 67.21%
Profit Quality N/A
Current Ratio 0.07
Quick Ratio 0.07
Altman-Z 0.18
F-Score5
WACC6.71%
ROIC/WACC0.07
Cap/Depr(3y)74.85%
Cap/Depr(5y)98.72%
Cap/Sales(3y)37.95%
Cap/Sales(5y)42.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%343.75%
EPS Next Y69.65%
EPS Next 2Y29.9%
EPS Next 3Y18.62%
EPS Next 5YN/A
Revenue 1Y (TTM)17.17%
Revenue growth 3Y18.25%
Revenue growth 5Y12.88%
Sales Q2Q%-8.51%
Revenue Next Year-3.73%
Revenue Next 2Y-0.7%
Revenue Next 3Y-1.45%
Revenue Next 5Y-1.07%
EBIT growth 1Y1.03%
EBIT growth 3Y-40.82%
EBIT growth 5Y-24.46%
EBIT Next Year1220.63%
EBIT Next 3Y139.72%
EBIT Next 5Y92.25%
FCF growth 1Y155.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y58.76%
OCF growth 3Y9.16%
OCF growth 5Y8.06%